Jupiter Neurosciences, Inc. Common Stock (NASDAQ:JUNS) — Stock Price
Jupiter Neurosciences, Inc. Common Stock (NASDAQ:JUNS) is currently trading at $5.31 USD, up 4.12% today. Over the past 52 weeks, shares have ranged between $0.08 and $5.31. This page tracks Jupiter Neurosciences, Inc. Common Stock's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Jupiter Neurosciences, Inc. Common Stock (JUNS) market capitalisation.
Jupiter Neurosciences, Inc. Common Stock (JUNS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Jupiter Neurosciences, Inc. Common Stock's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Jupiter Neurosciences, Inc. Common Stock Income Statement — Revenue, Profit & Earnings by Year
Jupiter Neurosciences, Inc. Common Stock's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $21.80K | $0.00 | $0.00 | $233.28K | $638.04K |
| Cost of Revenue | $4.23K | — | — | — | — |
| Gross Profit | $17.57K | — | — | $233.28K | $638.04K |
| Research & Development | $2.09 Million | $492.66K | $954.79K | $942.81K | $1.45 Million |
| SG&A | $6.84 Million | $2.60 Million | $2.92 Million | $2.72 Million | $3.10 Million |
| Total Operating Expenses | $8.93 Million | $3.09 Million | $3.87 Million | $3.67 Million | $4.55 Million |
| Operating Income | $-8.91 Million | $-3.09 Million | $-3.87 Million | $-3.43 Million | $-3.91 Million |
| EBITDA | $-8.58 Million | $-2.19 Million | $-4.56 Million | $-4.22 Million | $-4.09 Million |
| EBIT | — | $-3.09 Million | $-3.87 Million | $-3.43 Million | $-3.91 Million |
| Interest Expense | $66.02K | $248.37K | $218.71K | $740.85K | $113.99K |
| Income Before Tax | $-8.64 Million | $-2.44 Million | $-4.78 Million | $-4.96 Million | $-4.20 Million |
| Income Tax Expense | — | — | — | — | $179.17K |
| Net Income | $-8.64 Million | $-2.44 Million | $-4.78 Million | $-4.96 Million | $-4.38 Million |
Jupiter Neurosciences, Inc. Common Stock Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Jupiter Neurosciences, Inc. Common Stock's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $5.56 Million | $6.20 Million | $148.59K | $235.94K | $667.38K |
| Total Current Assets | $4.82 Million | $4.65 Million | $28.74K | $69.66K | $454.67K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $2.64K | $0.00 | — | — | — |
| Inventory | $159.79K | $0.00 | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $7.40 Million | $2.03 Million | $5.95 Million | $7.38 Million | $5.85 Million |
| Total Current Liabilities | $7.40 Million | $2.01 Million | $5.77 Million | $7.26 Million | $5.68 Million |
| Long-term Debt | — | — | $106.71K | — | — |
| Net Debt | $1.53 Million | $-3.55 Million | $2.22 Million | $1.83 Million | $320.60K |
| Total Stockholder Equity | $-1.83 Million | $4.17 Million | $-5.80 Million | $-7.14 Million | $-5.18 Million |
| Retained Earnings | $-34.67 Million | $-26.02 Million | $-23.58 Million | $-18.80 Million | $-13.84 Million |
Jupiter Neurosciences, Inc. Common Stock Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Jupiter Neurosciences, Inc. Common Stock generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-5.41 Million | $-3.91 Million | $-480.95K | $-1.25 Million | $-1.74 Million |
| Capital Expenditures | $4.00 | $4.00 | $3.00 | $4.00 | $4.00 |
| Free Cash Flow | $-5.41 Million | $-3.91 Million | $-480.95K | $-1.25 Million | $-1.74 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | $5.43 Million | $7.65 Million | $445.00K | $982.33K | $1.86 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $2.42 Million | $1.84 Million | $1.20 Million | $817.25K | $1.30 Million |
| Depreciation | — | $43.29K | — | — | — |
| Change in Cash | $19.83K | $3.74 Million | $-35.95K | $-266.17K | $122.60K |
Jupiter Neurosciences, Inc. Common Stock Earnings History — EPS Actual vs. Analyst Estimates
Track Jupiter Neurosciences, Inc. Common Stock's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 25, 2026 | -0.07 | -0.06 | -24.67% |
| Dec 03, 2025 | -0.07 | -0.08 | +12.50% |
| Sep 03, 2025 | -0.07 | -0.07 | +0.00% |
| May 28, 2025 | -0.05 | -0.03 | -66.67% |
| Feb 26, 2025 | -0.05 | -0.02 | -150.00% |
| Nov 27, 2024 | -0.02 | -0.02 | +0.00% |
| Jan 05, 2022 | -0.07 | 0.00 | — |
| Nov 09, 2021 | -0.03 | 0.00 | — |